Merck Sharp & Dohme Corp. v. Annora Pharma Private Limited et al
Plaintiff: Merck Sharp & Dohme Corp.
Defendant: Annora Pharma Private Limited and Hetero USA Inc.,
Case Number: 1:2021cv01006
Filed: July 9, 2021
Court: US District Court for the District of Delaware
Presiding Judge: Richard G Andrews
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. ยง 271
Jury Demanded By: None
Docket Report

This docket was last retrieved on July 14, 2021. A more recent docket listing may be available from PACER.

Date Filed Document Text
July 14, 2021 Filing 8 WAIVER OF SERVICE returned executed by Merck Sharp & Dohme Corp.: For Annora Pharma Private Limited waiver sent on 7/12/2021, answer due 9/10/2021. (Silver, Daniel)
July 14, 2021 Filing 7 WAIVER OF SERVICE returned executed by Merck Sharp & Dohme Corp.: For Hetero USA Inc., waiver sent on 7/12/2021, answer due 9/10/2021. (Silver, Daniel)
July 14, 2021 Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
July 13, 2021 Remark: MDL Panel has been notified of filing. (twk)
July 9, 2021 Filing 6 Summonses Issued (please complete the top portion of the form and print out for use/service). (twk)
July 9, 2021 Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp.. (twk)
July 9, 2021 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (twk)
July 9, 2021 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/25/2021. Date of Expiration of Patent: 11/24/2026 (May 24, 2027 - pediatric exclusivity expiration). Thirty Month Stay Deadline: 11/25/2023. (twk)
July 9, 2021 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk)
July 9, 2021 Filing 1 COMPLAINT filed against Annora Pharma Private Limited, Hetero USA Inc., - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3654080.) - filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(twk)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Merck Sharp & Dohme Corp. v. Annora Pharma Private Limited et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Merck Sharp & Dohme Corp.
Represented By: Michael P. Kelly
Represented By: Alexandra M. Joyce
Represented By: Daniel M. Silver
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Annora Pharma Private Limited
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Hetero USA Inc.,
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?